Hyun Chul Jung
Fortune : 3 M $ au 31/05/2026
Fortune : 3 M $ au 31/05/2026
Hyun Chul Jung is the founder of Beijing Sainuotai Biotechnology Co. Ltd. He currently holds a Director position at Immunotech Applied Science Ltd. He previously served as the Chief Executive Officer & Director at Pharos Vaccine, Inc. and is currently the Executive Director & Chief Strategy Officer at Immunotech Biopharm Ltd. Mr. Jung received his undergraduate and graduate degrees from Yonsei University in 1985 and 1987, respectively.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
IMMUNOTECH BIOPHARM LTD 5,26 % | 10/09/2025 | 33 524 359 ( 5,26 % ) | 3 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
Immunotech Applied Science Ltd. | Directeur/Membre du Conseil | 01/11/2006 |
Beijing Sainuotai Biotechnology Co. Ltd. | Fondateur | - |
| Sociétés | Poste | Fin |
|---|---|---|
| IMMUNOTECH BIOPHARM LTD | Directeur/Membre du Conseil | 24/03/2023 |
Pharos Vaccine, Inc.
Pharos Vaccine, Inc. BiotechnologyHealth Technology Engages in research, development and production of bio medicine such as vaccines and immune therapeutics | Directeur Général | 01/03/2019 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Yonsei University
Yonsei University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharos Vaccine, Inc.
Pharos Vaccine, Inc. BiotechnologyHealth Technology Engages in research, development and production of bio medicine such as vaccines and immune therapeutics | Health Technology |
Immunotech Biopharm Ltd.
Immunotech Biopharm Ltd. Pharmaceuticals: MajorHealth Technology Researches and develops, manufactures and commercializes immune cell products for treatments of cancers | Health Technology |
Immunotech Applied Science Ltd. | |
Beijing Sainuotai Biotechnology Co. Ltd. |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national